FibroGen, Inc (FGEN) Dividend History

Company News

• Amid Mounting Pressure In China, AstraZeneca Buys FibroGen's Chinese Unit For $160 Million

  AstraZeneca has acquired FibroGen's Chinese subsidiary for $160 million, strengthening its position in the Chinese market and enabling FibroGen to focus on its pipeline development in the US.

  Benzinga
• Liver Fibrosis Market Is Expected to Reach USD 43.98 Billion By 2030

  The global liver fibrosis market is expected to grow from $17.25 billion in 2021 to $43.98 billion by 2030, driven by the increasing prevalence of liver disorders, adaptation of unhealthy lifestyles, and the rising geriatric population. The North American region dominates the market due to high healthcare expenditure and the presence of major players.

  GlobeNewswire Inc.

  Featured Companies: BMY DVAX GILD JNJ MRK PFE VRTX
• Zoetis (ZTS) Beats Q1 Earnings and Revenue Estimates

  Zoetis (ZTS) delivered earnings and revenue surprises of 2.99% and 2.36%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research

  Featured Companies: ZTS
• HP's stock slumps on cautious outlook, VinFast shares on the move again and other stocks in the spotlight

  HP, Box, VinFast Auto and Ambarella are among the stocks on the move.

  MarketWatch

  Featured Companies: ALKS AMBA BF.B BOX CGC EBS HPQ LYFT MCFT MSOS NVDA OTLK PODD TLRY VFS VRA
• Wall Street Breakfast: The Week Ahead

  Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.

  Seeking Alpha

  Featured Companies: AAPL AZZ BAC BK C COTY GS IBRX JBSS JPM KRUS LEVI MS OLN OZK PNC ROIV SLP SPCE STT TFC TSLA UONE VRM WFC XAIR